Download Chapter_018

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project

Document related concepts
no text concepts found
Transcript
Chapter 18
Adrenergic Antagonists
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc.
Adrenergic Antagonists




Cause direct blockade of adrenergic
receptors
With one exception, all produce reversible
(competitive) blockade
Most adrenergic antagonists are more
selective than the adrenergic agonists.
Two major groups


Alpha-adrenergic blocking agents
Beta-adrenergic blocking agents
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc.
2
Adrenergic Antagonists




Alpha-adrenergic antagonists I: therapeutic
and adverse response to alpha blockade
Alpha-adrenergic antagonists II: properties of
individual alpha blockers
Beta-adrenergic antagonists I: therapeutic
and adverse responses to beta blockade
Beta-adrenergic antagonists II: properties of
individual beta blockers
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc.
3
Therapeutic Applications of
Alpha Blockade

Essential hypertension



Lowers blood pressure by blocking alpha1
receptors on arterioles and veins, causing
vasodilation
Reversal of toxicity from alpha1 agonists
Benign prostatic hyperplasia

Reduced contraction of smooth muscle in the
bladder neck and prostatic capsule
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc.
4
Therapeutic Applications of
Alpha Blockade

Pheochromocytoma




Catecholamine-secreting tumor
Usually located in adrenal medulla
Principal cause of hypertension is usually
activation of alpha1 receptors, but beta1 receptors
can also contribute
Treatment: best option is surgery
• Inoperable tumor: alpha1 antagonists suppress
hypertension
• Surgery: before surgery, manipulation of tumor can
cause massive catecholamine release
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc.
5
Therapeutic Applications of
Alpha Blockade

Raynaud’s disease




Peripheral vascular disorder
Vasospasms in the toes and fingers
Suppress symptoms by preventing alphamediated vasoconstriction
Ineffective against other peripheral vascular
disorders that involve inappropriate
vasoconstriction
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc.
6
Adverse Effects of Alpha1 Blockade



Detrimental effects result from blockade of
alpha1 receptors
Effects from alpha2 receptors are minor
Orthostatic hypotension





Blockade of alpha receptors on veins
Reduced muscle tone in the venous wall
Upon standing, blood pools in the veins
Return of blood to the heart reduced
Cardiac output decreased: blood pressure drops
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc.
7
Adverse Effects of Alpha1 Blockade

Reflex tachycardia


Nasal congestion


Dilates the blood vessels of the nasal mucosa
Inhibition of ejaculation



Reflex to increase heart rate via the autonomic nervous
system (ANS)
Alpha1 activation required for ejaculation
Impotence is reversible; resolves when drug is discontinued
Sodium retention and increased blood volume


Reduced BP promotes renal retention of sodium and water
Usually combined with diuretic when used for hypertension
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc.
8
Adverse Effects of Alpha2 Blockade

The most significant adverse effect
associated with alpha2 blockade—
potentiation of the reflex tachycardia
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc.
9
Alpha-Adrenergic Antagonists II







Prazosin
Terazosin
Doxazosin
Tamsulosin
Alfuzosin
Phentolamine
Phenoxybenzamine
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc.
10
Prazosin




Actions and uses
Pharmacokinetics
Adverse effects
Preparations, dosage, and administration
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc.
11
Terazosin




Actions and uses
Pharmacokinetics
Adverse effects
Preparations, dosage, and administration
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc.
12
Doxazosin




Actions and uses
Pharmacokinetics
Adverse effects
Preparations, dosage, and administration
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc.
13
Tamsulosin





Actions and uses
Pharmacokinetics
Adverse effects
Drug interactions
Preparations, dosage, and administration
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc.
14
Alfuzosin





Actions and uses
Pharmacokinetics
Adverse effects
Drug interactions
Preparations, dosage, and administration
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc.
15
Phentolamine



Actions and uses
Adverse effects
Preparations, dosage, and administration
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc.
16
Phenoxybenzamine



Actions and uses
Adverse effects
Preparations, dosage, and administration
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc.
17
Beta-Adrenergic Antagonists I

Therapeutic applications of beta blockade




Angina pectoris
Hypertension
Cardiac dysrhythmias
Myocardial infarction
 Heart failure
 Hyperthyroidism
 Migraine
 Stage fright
 Pheochromocytoma
 Glaucoma
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc.
18
Beta-Adrenergic Antagonists I

Adverse effects of beta blockade

Adverse effects involve both beta1 and beta2
blockade.
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc.
19
Beta-Adrenergic Antagonists I

Adverse effects of beta1 blockade





Bradycardia
Reduced cardiac output
Precipitation of heart failure
AV heart block
Rebound cardiac excitation
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc.
20
Beta-Adrenergic Antagonists I

Adverse effects of beta2 blockade


Bronchoconstriction
Inhibition of glycogenolysis
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc.
21
Beta-Adrenergic Antagonists II:
Propranolol




Pharmacologic effects
Pharmacokinetics
Therapeutic uses
Adverse effects




Bradycardia
AV heart block
Heart failure
Rebound cardiac excitation
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc.
22
Beta-Adrenergic Antagonists II:
Propranolol

Adverse effects (cont’d)




Bronchoconstriction
Inhibition of glycogenolysis
CNS effects
Precautions, warnings, and contraindications



Severe allergy
Diabetes
Cardiac, respiratory, and psychiatric disorders
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc.
23
Beta-Adrenergic Antagonists II:
Propranolol

Drug interactions



Calcium channel blockers
Insulin
Preparations, dosage, and administration



General dosing considerations
Preparations
Dosage
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc.
24
Beta-Adrenergic Antagonists II:
Metoprolol






Pharmacologic effects
Pharmacokinetics
Therapeutic uses
Adverse effects
Precautions, warnings, and contraindications
Preparations, dosage, and administration
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc.
25
Beta-Adrenergic Antagonists II:
Other Beta-Adrenergic Blockers






Receptor specificity: selective blockade
Pharmacokinetics
Therapeutic uses
Adverse effects
Intrinsic sympathomimetic activity (partial
agonist activity)
Dosage and administration
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc.
26
Related documents